IDIOPATHIC PULMONARY FIBROSIS: WHETHER WE ARE CLOSE TO CONVENTIONAL GUIDELINES FOR DIAGNOSIS AND TREATMENT?


Citar

Texto integral

Resumo

The article discusses the potentials for translation of recommendations of several professional medical societies for the diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) published in the 2011 in real clinical practice. It is emphasized that the risk factors and approaches to the diagnosis of IPF are now well established; interdisciplinary approach to the management of IPF proposed by a committee of experts the key is crucial. Difficulties in determining therapeutic tactics and lack of clear evidence of the effectiveness of most currently used drugs should be an incentive for new controlled clinical trials.

Bibliografia

  1. Radhu G, Collard H, Egan J, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Treatment. Am J Respir Crit Care Med 2011;183:788-824.
  2. Borchers AT, Chang C, Keen CL, Gershwin ME. Idiopathic pulmonary fibrosis-an epidemiological and pathological review. Clin Rev Allergy Immunol 2011;40(2):117-34.
  3. Попова Е.Н. Идиопатический фиброзирующий альеволит (клинико-морфологическая характеристика, механизмы прогрессирования, прогноз). Дисс. докт. мед. наук. М., 2005.
  4. Allam J, Limper A. Idiopathic pulmonary fibrosis: is it a family disease? Curr Opin Pulm Med 2006;12:312-17.
  5. Checa M, Ruiz V, Montaño M, et al. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum Genet. 2008;124(5):465-72.
  6. Korthagen NM, van Moorsel CH, Kazemier KM, et al. IL1RN genetic variations and risk of IPF: a meta-analysis and mRNA expression study. Immunogenetics. 2012 Feb 10. [Epub ahead of print]
  7. Riha RL, Yang IA, Rabnott GC et al. Cytokine gene polymorphisms in idiopathic pulmonary fibrosis. Intern Med J. 2004;34(3):126-29.
  8. Molina-Molina M, Xaubet A, Li X, et al. Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression. Eur Respir J 2008;32(4):1004-08.
  9. Selman M, Carrillo G, Estrada A, et al. Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One 2007;2(5):e482.
  10. Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173(2):188-98.
  11. de Cremoux H, Bernaudin JF, Laurent P, et al. Interactions between cigarette smoking and the natural history of idiopathic pulmonary fibrosis. Chest 1990;98(1):71-6.
  12. Schwartz DA, Merchant RK, Helmers RA, et al. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991;144(3 Pt 1):504-06.
  13. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997;155(1):242-48.
  14. Antoniou KM, Hansell DM, Rubens MB, et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008;177(2):190-94.
  15. Gustafson T, Dahlman-Hoglund A, Nilsson K et al. Occupational exposure and severe pulmonary fibrosis. Respir Med 2007;101:2207-12.
  16. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc 2006;3:293-98.
  17. Stewart JP, Egan JJ, Ross AJ, et al. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1999;159:1336-41.
  18. Zamo A, Poletti V, Reghellin D, et al. HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:123-28.
  19. Irving WL, Day S, Johnston ID. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis. 1993;148(6 Pt 1):1683-84.
  20. Ueda T, Ohta K, Suzuki N, et al. diopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992;146(1):266-68.
  21. Meliconi R, Andreone P, Fasano L, et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax 1996;51(3):315-17.
  22. Arase Y, Suzuki F, Suzuki Y, et al. Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. World J Gastroenterol 2008;14(38):5880-86.
  23. Tarantino G, Conca P, Ariello M, et al. The use of interferon-alpha in a small cohort of patients with a type of idiopathic pulmonary fibrosis, probably post-cryoglobulinaemia, hepatitis C virus related. Eur J Gastroenterol Hepatol 2005;17(12):1439-40.
  24. Fahim A, Crooks M, Hart SP. Gastroesophageal reflux and idiopathic pulmonary fibrosis: a review. Pulm Med 2011;2011:634613.
  25. Tobin RW, Pope CE 2nd, Pellegrini CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158(6):1804-08.
  26. Taniguchi H, Ebina M, Kondoh Y, et al.; Pirfenidone Clinical Study Group in Japan. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010;35(4):821-29.
  27. Algar FJ, Espinosa D, Moreno P, et al. Results of lung transplantation in idiopathic pulmonary fibrosis patients. Transplant Proc 2010;42(8):3211-13.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies